Hutch News
Results per Page:
Intermittent hormone therapy for prostate cancer inferior to continuous therapy
Cathy Tangen contributes to international study, finding on again-off again prostate cancer treatment has quality of life benefits, but continuous therapy improves overall survival
Lower income cancer patients less likely to join clinical trials
Joseph Unger-led study finds poor patients stymied by financial, logistical concerns, blocking representation and access to latest therapies
Press Lab's Till wins SWOG award
Brian Till, research associate, studies mantle cell lymphoma
Study re-evaluation shows beneficial findings for finasteride
New data shows the drug can reduce risk of prostate-cancer development